Roivant Sciences Ltd. Common Shares ROIV

$38.88 +6.17% at last close

Recent SEC Filings

FormDescriptionFiledDocument
4 FORM 4 2026-11-05 View →
4 FORM 4 2026-10-30 View →
4 FORM 4 2026-10-27 View →
4 FORM 4 2026-10-27 View →
4 FORM 4 2026-10-27 View →
4 FORM 4 2026-10-22 View →
8-K 8-K 2026-10-21 View →
4 FORM 4 2026-10-20 View →
4 FORM 4 2026-10-20 View →
4 FORM 4 2026-10-05 View →
4 FORM 4 2026-10-05 View →
4 FORM 4 2026-10-02 View →
4 FORM 4 2026-10-02 View →
4 FORM 4 2026-10-02 View →
4 FORM 4 2026-10-02 View →
4 FORM 4 2026-09-22 View →
4 FORM 4 2026-09-22 View →
4 FORM 4 2026-09-18 View →
4 FORM 4 2026-09-18 View →
4 FORM 4 2026-09-18 View →
4 FORM 4 2026-09-18 View →
4 FORM 4 2026-09-18 View →
4 FORM 4 2026-09-18 View →
8-K 8-K 2026-09-18 View →
4 FORM 4 2026-09-17 View →
4 FORM 4 2026-09-17 View →
4 FORM 4 2026-09-14 View →
4 FORM 4 2026-09-14 View →
4 FORM 4 2026-09-14 View →
4 FORM 4 2026-09-14 View →
4 FORM 4 2026-09-14 View →
4 FORM 4 2026-09-10 View →
8-K 8-K 2026-09-08 View →
4 FORM 4 2026-09-01 View →
8-K 8-K 2026-08-28 View →
8-K 8-K 2026-08-27 View →
4 FORM 4 2026-08-24 View →
4 FORM 4 2026-08-24 View →
4 FORM 4 2026-08-21 View →
4 Insider transaction 2026-08-18 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$38.88
Market Cap
$26.45 billion
52-Week Range
$15.25 – $42.50
Average Volume
6.88 million shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.